Tony Reeves

Mr Tony Reeves, Chair

Tony Reeves is an experienced senior executive and director. He served as Chief Financial Officer of several Australian public companies, most recently Treasury Wine Estates Limited, and prior to that Foster's Group Limited, another global premium beverage company. Prior to Foster's, he was CFO of OneSteel Limited, a fully integrated global manufacturer and distributor of steel and finished steel products, which was demerged from BHP Billiton. Earlier in his career, he was CFO of Orica Explosives after holding several senior executive roles in strategy, finance, marketing and IT with the ICI Group in the UK, USA, and Australia. Tony is a past President of the Group of 100, an organisation of CFOs from Australia's largest businesses. He is a graduate of the Harvard Business School’s Program for Management Development. Tony is a Fellow of CPA Australia, a member of the Australian Institute of Company Directors and the Financial Executives Institute. He is Chair of Hewitt Cattle Australia Pty Ltd and Arcadian Organic and Natural Meat Company Pty Ltd and is a Director of Private Banking Services Ltd. He joined the SVI Board in March 2017.

Mr Michael Burn

Mr Michael Burn

Michael Burn is an experienced finance executive and company director. He has enjoyed a long career in Investment Banking and is Deputy Chairman of Flagstaff Partners, a boutique corporate finance firm. Michael is also a Director of PFD Food Services Group and a member of the Board of Trustees of the Melbourne Convention and Exhibition Centre Trust. Previously Michael was an Executive Director with the Macquarie Group, Chairman of the Victoria Racing Club, a member of Council at Loreto Mandeville Hall and a Director of Prince Henry’s Institute of Medical Research. Michael joined the SVI Board in 2019.


Ms Melanie Eagle

Melanie Eagle’s many years of governance experience span local government, community services, health, disability, and violence against women, as well as having worked professionally in women’s policy, law reform, equal opportunity, city strategic planning and private legal practice. For the past decade, Melanie served as CEO of LiverWELL (previously Hepatitis Victoria) and on the Board of Hepatitis Australia. At LiverWELL Melanie expanded the remit in relation to hepatitis B and then broader liver disease, and most critically built the participation of those with lived experience. Other governance roles currently held by Melanie include the Inaugural Chair of the Disability Worker Registration Board, Director of Alfred Health and a Queen Victoria Women’s Centre Trust member. Previous governance roles include Inaugural Chair of Respect Victoria, Star Health, Hanover Welfare Services, and Prahran Mission. She is also a former Mayor of the City of St Kilda. Melanie has qualifications in Arts, Social Work, the Law, and International Development and is a Graduate of the Australian Institute of Company Directors.

Karen Inge

Ms Karen Inge

Karen Inge is an accredited practising dietitian with over 30 years’ experience, specialising in the areas of sports dietetics and nutrition communication. Ms Inge is the founding member and Past President of Sports Dietitians Australia and founding Head of Nutrition at the Victorian Institute of Sport. She has been a Director of the Institute of Health and Fitness, Melbourne since 1989. She is a respected  nutrition commentator for media and is heavily involved in community service and philanthropy.

Thomas Kay

Professor Thomas WH Kay

Professor Kay is Director of SVI. He holds a Professorial appointment within the Department of Medicine, St Vincent’s Hospital and The University of Melbourne. He also holds the position of Honorary Endocrinologist at St Vincent’s Hospital. Professor Kay’s research interests are in the area of autoimmunity, particularly of type 1 (juvenile) diabetes. Professor Kay's research biography is HERE.


Professor Erwin Loh

Professor Loh is national Chief Medical Officer and Group General Manager Clinical Governance for St Vincent's Health Australia. Prior to this, he was the Chief Medical Officer of Monash Health for 10 years, and before that Deputy Chief Medical Officer at the Peter MacCallum Cancer Institute. He has also worked as a lawyer for Sparke Helmore after working as a clinician. He has qualifications in medicine, law, management and governance. He is currently Vice President and on the Board of the Royal Australasian College of Medical Administrators (RACMA), where he was previously Chair of the Finance and Audit Board Committee. He received the Distinguished Fellow Award from RACMA in 2017 for “commitment to governance, research and publication”. He has previously been a director on the boards of the Hudson Institute of Medical Research, Monash Health Research Precinct Pty Ltd, Australian Medical Association (Victoria) and Law Institute of Victoria. He is a Graduate and Fellow of the Australian Institute of Company Directors. He is adjunct Professor at the University of Melbourne, Monash University and Macquarie University. He is currently a partner investigator in NHMRC-funded research projects, one looking at bullying and harassment in health, another at women in health leadership. He has published over 90 papers, 6 book chapters, 4 books, presented at over 150 national and international conferences, and teaches and carries out research in health law, clinical governance, medical leadership and ethics.

Simon Marton

Mr Simon Marton

Simon Marton is Chief Executive Officer of Starward Distillery, Australia’s largest premium whisky producer located in Port Melbourne, Victoria. Prior to Starward Simon spent over 20 years with Treasury Wine Estates and the Fosters Group, most recently as Global Chief Marketing Officer for Treasury Wine Estates, the largest publicly listed wine company in the world. Simon has over 25 years’ experience in strategy, marketing, communications, PR, export and the beverage industry and was rated in Australia’s Top 50 CMO’s in 2015, 2016 and 2017 by CMO Magazine. Simon has an MBA from Monash University and joined the SVI Board in November 2019.

Mike McGuckin

Professor Mike McGuckin

Professor Mike McGuckin is the Deputy Dean in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne, where he oversees the strategic direction of research and the International, Engagement and People & Culture portfolios. Mike is the author of more than 170 scientific publications, with his research currently focused on mucosal infection, chronic inflammation and cancer in the gastrointestinal tract, and diabetes. Mike has held four patents and his intellectual property is being developed in the startup company, Jetra Therapeutics. Mike is heavily involved in national and international peer review, has served on the Editorial Boards of multiple international journals, and is the immediate Past-President for the international Society for Mucosal Immunology. Mike has served previously on multiple Boards, including for the Cancer Council Queensland, and is currently a Director on the Boards of St Vincent’s Institute for Medical Research and the Melbourne Genomics Health Alliance.

Chris Pearce

The Honourable Chris Pearce, Deputy Board Chair

The Honourable Chris Pearce has been a Member of the Ministry in the Federal Government of Australia responsible for financial services, business law and consumer affairs and later, in Opposition, as Shadow Minister. Throughout his career, Chris has been an energetic non-executive director on boards, including having been Chairman & Board Director at Anglicare Victoria, the State’s largest child and welfare organisation, Chairman of the Board for Global Voices, Board Director of the Victorian Funds Management Corporation (VFMC) and a Board Director for Renewtek Pty Ltd. He is presently a Board Director of the McKinnon Institute and the External Representative on the Learning and Engagement Board Committee of the Melbourne Symphony Orchestra. Chris has been a former Associate Fellow of The CEO Institute, former Member of The Economist CEO Forum and a former Member of the Australian National Academy of Music. He is presently a Fellow of the Australian Institute of Company Directors, Fellow of the Australian Marketing Institute, Member of the Royal Victorian Association of Honorary Justices, and a Member of the Royal School of Church Music.

Fiona Rowland

Ms Fiona Rowland

Fiona is an experienced Non-Executive Director and former CEO, in public, private, government and for-purpose sectors, with significant experience in leading established and disruptor businesses through transformational and regulatory change. Fiona  has extensive experience in financial services, asset management and infrastructure across wide-ranging customer segments in public, private, government, listed and disruptor environments. Over her 23-year executive career, Fiona held senior executive management, CEO and Managing Director roles at the Bennelong Group, National Australia Bank, UBS AG, UBS Wealth Management, and Australia and New Zealand Banking Group.  Fiona is currently the Non-Executive Chair of Macquarie Investment Services Limited and Non-Executive Director of Macquarie Life Limited, Melbourne Water Corporation, Infrastructure Specialist Asset Management Limited (part of the UK Foresight Group Holdings Limited FSG:LSE), where she also Chairs the Audit, Compliance, Risk Management Committee. Fiona is also an Independent Member of the Audit & Risk Committee of Unisuper Limited and an Advisory Board member of Kearney Australia part of the global management consulting group. Fiona holds a Bachelor of Arts, a Bachelor of Laws (Honors) and is admitted as a legal practitioner in Victoria. She is also a Graduate of the Australian Institute of Company Directors.

Ian Smith

Professor Ian Smith

Professor Ian Smith is a research academic who served as Vice-Provost (Research and Research Infrastructure) at Monash University where he had responsibility for research infrastructure, strategy and research alliances. Ian is an accomplished medical researcher and a recognised leader in his field – applying proteomics technologies to study proteases involved in brain and cardiovascular function. He co-founded a proteomics-based, publicly-listed, biotechnology company and he continues to collaborate and consult widely with the pharmaceutical and biotechnology industries. Ian is an experienced board member and sits on a number of national and international government and non-government advisory and governing boards and committees, many with a strong industry focus. Ian’s unique background in business and research drives his passion to get researchers and industry collaborating and applying academic and institutional based research and research infrastructure to innovate. Ian strongly believes that by Improving the translation of medical research into commercial outcomes will help drive innovation in Australia, grow successful Australian businesses and lead to better health outcomes for the nation.

Marcus Tierney

Dr Marcus Tierney

Dr Tierney is a taxation Partner at PwC in Melbourne. He currently manages and advises a broad cross-section of listed and private companies within the pharmaceutical, biotechnology, infrastructure, manufacturing and ICT industries in respect of R&D taxation and government grants and incentives. Further, he also works closely with small and medium sized enterprises from a broad range of industries to identify Angel, VC and other funding opportunities. Marcus was previously a member of the board of the O'Brien Institute.

Michael Wachtel

Mr Michael Wachtel

Michael Wachtel was appointed to the Future Fund Board by Scott Morrison and Mathias Cormann in 2016, to the SEEK Board in 2018 and to the PACT Board in 2020. He was a Senior Adviser to Credit Suisse (2016-2018) until he moved into the Credit Suisse NED Suite in April 2018. He was the Chairman (Asia Pacific & Oceania) of Ernst & Young (EY)(2010-2015); a member of the EY Global Governance Council (2007-2015); Global Risk Committee (2013-2016) and Global Leader for Tax Quality and Risk (2013-2016). He was an adviser to Australia’s leading multinationals and high net worth families for over 30 years and co-authored the BCA White Paper ‘Removing Tax Barriers to International Growth’ (2001). Michael is a past Board member of ACMI; past President of the International Fiscal Association (Australia); and past Member of the Tax Advisory Board and Senior Fellow in the University of Melbourne Law Faculty.

Kathy Williams

The Honourable Kathy Williams

The Honourable Kathy Williams was a Justice of the Supreme Court of Victoria from 2002 to 2015 and a Judge of the Victorian County Court from 1999.She initially practised as a solicitor and taught in the Law Schools at The University of Melbourne and Monash University. She then joined the Victorian Bar, specialising in commercial law. She was a director of Barristers’ Chambers Limited and Over 50s Building Society. At the Supreme Court, Kathy was Principal Judge of the Common Law Division and President of the Victorian Forensic Leave Panel. Kathy is currently also a director of Launch Housing and President of Court Network.